Voglinorm-0.2/Voglinorm-0.3 Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Gastrointestinal disorders eg, diarrhea, loose stools, abdominal pain, constipation, anorexia, nausea, vomiting, abdominal pain and loss of appetite may occur with the combination of voglibose. These adverse reactions occur most frequently during initiation of therapy and resolve spontaneously in most cases. To prevent them, it is recommended that metformin hydrochloride be taken in 2 or 3 daily doses during or after meals. A slow increase of the dose may also improve gastrointestinal tolerability.
Skin and Subcutaneous Tissue Disorders: Very rarely skin reactions eg, erythema, pruritus, and urticaria have been seen. In such a case, voglibose tablets should be discontinued. Increased AST or ALT may also occur. When voglibose is used in combination with other antidiabetic drugs, hypoglycemia may occur (0.1% to <5%).

View ADR Monitoring Form

Voglinorm-0.2/Voglinorm-0.3 Adverse Reactions

voglibose

Manufacturer:

Micro Labs

Distributor:

Zizawa Healthcare